Skip to main content

Table 2 Menopausal stage, menopausal symptoms and health-related quality of life in women resident in Harare, by HIV status

From: Menopausal symptoms by HIV status and association with health-related quality of life among women in Zimbabwe: a cross-sectional study

 

Total

(n = 378)

HIV –

(n = 193)

HIV +

(n = 185)

p value *

Menopausal stage, n (%)

    

 Pre-menopause

173(45.8)

94(48.7)

79(42.7)

0.278

 Peri-menopause

51(13.5)

28(14.5)

23(12.4)

 

 Post menopause

154(40.7)

71(36.8)

83(44.9)

 

Total MRS symptoms, n (%)

    

 No, little (≤ 4)

177(46.8)

101(52.3)

76(41.1)

0.005

 Mild (5–8)

97(25.7)

52(26.9)

45(24.3)

 

 Moderate (9–16)

81(21.4)

35(18.1)

46(24.9)

 

 Severe (≥ 17)

23(6.1)

5(2.6)

18(9.7)

 

Somatic symptomsub-domain, n (%)

    

 No, little (0–2)

190(50.3)

102(52.9)

88(47.6)

0.250

 Mild (3–4)

91(24.1)

50(25.9)

41(22.2)

 

 Moderate (5–8)

82(21.7)

35(18.1)

47(25.4)

 

 Severe (≥ 9)

15(4.0)

6(3.1)

9(4.9)

 

Psychological symptomsub-domain, n (%)

    

 No, little (0–1)

228(60.3)

135(70.0)

93(50.3)

< 0.001

 Mild (2–3)

75(19.8)

30(15.5)

45(24.3)

 

 Moderate (4–6)

53(14.0)

26(13.5)

27(14.6)

 

 Severe (≥ 7)

22(5.8)

2(1.0)

20(10.8)

 

Urogenital symptomsub-domain, n (%)

    

 No, little (0)

172(45.5)

100(51.8)

72(38.9)

0.009

 Mild (1)

63(16.7)

36(18.7)

27(14.6)

 

 Moderate (2–3)

88(23.3)

35(18.1)

53(28.7)

 

 Severe (≥ 4)

55(14.5)

22(11.4)

33(17.8)

 

HRQoL, mean (SD)

26.4(3.5)

26.5(3.3)

26.3(3.7)

0.642

  1. Participants’ menopausal symptoms by HIV status. *p values generated using Chi-square tests of association for categorical variables and t-test for normally distributed continuous variables, MRS: Menopause Rating Scale, HRQoL: Health Related Quality of Life